Simple Modifications of Phase I Trial Designs Could Reduce Time Required for New Advances
A recent study found that phase I queue designs were associated with a reduction in the expected study duration without changing risk limits or maximum tolerated dose determination when compared to the original parent design.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
More News: Cancer & Oncology | Study